Related Experiment Videos

Henoch-Schönlein purpura with intracerebral hemorrhage

Tadashi Imai1, Hitoshi Okada, Masanori Nanba

  • 1Department of Pediatrics, Kagawa Medical University, Ikenobe 1750-1, Miki, Kitagun 761-0793, Japan. taboimai@kms.ac.jp

Brain & Development
|March 14, 2002
PubMed

Insights

Henoch-Schönlein purpura (HSP) can rarely cause severe brain bleeds (intracerebral hemorrhage). This case highlights a severe bleed in a child with HSP, linked to low factor XIII activity, which was successfully treated.

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Vascular Disorders

Background:

  • Henoch-Schönlein purpura (HSP) is a common childhood vasculitis, typically presenting with rash, arthritis, abdominal pain, and glomerulonephritis.
  • Intracerebral hemorrhage (ICH) is an extremely rare but devastating complication of HSP.
  • The underlying mechanisms for ICH in HSP remain poorly understood.

Observation:

  • A 7-year-old girl with Henoch-Schönlein purpura presented with massive intracerebral hemorrhage.
  • Cranial CT scan confirmed extensive bleeding in the left parietal and right parieto-temporal-occipital regions.
  • Initial assessment revealed no hypertension or general coagulation abnormalities, but markedly reduced factor XIII activity (9%).

Findings:

  • The intracerebral hemorrhage in this case is strongly suspected to be a direct consequence of severe factor XIII deficiency.
  • Prompt administration of factor XIII concentrate following the onset of ICH prevented further enlargement of the hemorrhagic region.
  • This represents the first reported case of HSP with ICH where factor XIII levels were measured and correlated with the event.

Implications:

  • This case underscores the critical role of factor XIII in hemostasis and suggests it as a potential factor in HSP-related ICH.
  • Measurement of factor XIII activity should be considered in children with HSP presenting with neurological symptoms or suspected intracranial bleeding.
  • Early factor XIII replacement therapy may be a crucial intervention for managing ICH in the context of HSP.

Related Concept Videos